Insider Transactions in Q4 2020 at Ionis Pharmaceuticals Inc (IONS)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 23
2020
|
B Lynne Parshall Director |
SELL
Open market or private sale
|
Direct |
10,000
-14.82%
|
$600,000
$60.0 P/Share
|
|
Dec 17
2020
|
Stanley T Crooke Exec Chairman of the Board |
SELL
Open market or private sale
|
Indirect |
1,407
-88.99%
|
$70,350
$50.5 P/Share
|
|
Dec 15
2020
|
Stanley T Crooke Exec Chairman of the Board |
SELL
Open market or private sale
|
Indirect |
39,000
-6.1%
|
$1,911,000
$49.77 P/Share
|
|
Dec 07
2020
|
Stanley T Crooke Exec Chairman of the Board |
SELL
Open market or private sale
|
Indirect |
11,000
-0.85%
|
$561,000
$51.68 P/Share
|
|
Dec 04
2020
|
C Frank Bennett EVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
7,947
-19.66%
|
$405,297
$51.04 P/Share
|
|
Dec 04
2020
|
C Frank Bennett EVP, Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,947
+16.43%
|
$309,933
$39.87 P/Share
|
|
Dec 04
2020
|
Brett P Monia Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
23,840
-45.22%
|
$1,215,840
$51.04 P/Share
|
|
Dec 04
2020
|
Brett P Monia Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,840
+31.14%
|
$929,760
$39.87 P/Share
|
|
Dec 02
2020
|
Brett P Monia Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
21,160
-42.29%
|
$1,079,160
$51.32 P/Share
|
|
Dec 02
2020
|
Brett P Monia Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,160
+29.72%
|
$825,240
$39.87 P/Share
|
|
Dec 02
2020
|
C Frank Bennett EVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
7,053
-17.84%
|
$359,703
$51.32 P/Share
|
|
Dec 02
2020
|
C Frank Bennett EVP, Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,053
+15.14%
|
$275,067
$39.87 P/Share
|
|
Nov 25
2020
|
B Lynne Parshall Director |
SELL
Open market or private sale
|
Direct |
3,590
-5.05%
|
$179,500
$50.05 P/Share
|
|
Nov 25
2020
|
B Lynne Parshall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,590
+4.81%
|
$140,010
$39.87 P/Share
|
|
Nov 25
2020
|
Richard S Geary EVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct |
11,920
-28.14%
|
$596,000
$50.05 P/Share
|
|
Nov 25
2020
|
Richard S Geary EVP, Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,920
+21.96%
|
$464,880
$39.87 P/Share
|
|
Nov 25
2020
|
Stanley T Crooke Exec Chairman of the Board |
SELL
Open market or private sale
|
Direct |
12,990
-86.54%
|
$649,500
$50.05 P/Share
|
|
Nov 25
2020
|
Stanley T Crooke Exec Chairman of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
12,990
+46.39%
|
$506,610
$39.87 P/Share
|
|
Nov 25
2020
|
Elizabeth L Hougen EVP, Finance & CFO |
SELL
Open market or private sale
|
Direct |
21,680
-40.02%
|
$1,084,000
$50.05 P/Share
|
|
Nov 25
2020
|
Elizabeth L Hougen EVP, Finance & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
21,680
+28.58%
|
$845,520
$39.87 P/Share
|
|
Nov 24
2020
|
B Lynne Parshall Director |
SELL
Open market or private sale
|
Direct |
710
-1.04%
|
$35,500
$50.82 P/Share
|
|
Nov 24
2020
|
B Lynne Parshall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
710
+1.03%
|
$27,690
$39.87 P/Share
|
|
Nov 24
2020
|
Richard S Geary EVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct |
2,380
-7.25%
|
$119,000
$50.83 P/Share
|
|
Nov 24
2020
|
Richard S Geary EVP, Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,380
+6.76%
|
$92,820
$39.87 P/Share
|
|
Nov 24
2020
|
Elizabeth L Hougen EVP, Finance & CFO |
SELL
Open market or private sale
|
Direct |
4,320
-11.73%
|
$216,000
$50.83 P/Share
|
|
Nov 24
2020
|
Elizabeth L Hougen EVP, Finance & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,320
+10.5%
|
$168,480
$39.87 P/Share
|
|
Nov 24
2020
|
Stanley T Crooke Exec Chairman of the Board |
SELL
Open market or private sale
|
Direct |
2,590
-56.17%
|
$129,500
$50.83 P/Share
|
|
Nov 24
2020
|
Stanley T Crooke Exec Chairman of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
2,590
+35.97%
|
$101,010
$39.87 P/Share
|
|
Nov 23
2020
|
B Lynne Parshall Director |
SELL
Open market or private sale
|
Direct |
3,200
-4.53%
|
$160,000
$50.12 P/Share
|
|
Nov 23
2020
|
B Lynne Parshall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,200
+4.33%
|
$124,800
$39.87 P/Share
|
|
Nov 23
2020
|
Richard S Geary EVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct |
10,700
-26.0%
|
$535,000
$50.11 P/Share
|
|
Nov 23
2020
|
Richard S Geary EVP, Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,700
+20.64%
|
$417,300
$39.87 P/Share
|
|
Nov 23
2020
|
Elizabeth L Hougen EVP, Finance & CFO |
SELL
Open market or private sale
|
Direct |
19,000
-22.04%
|
$950,000
$50.11 P/Share
|
|
Nov 23
2020
|
Elizabeth L Hougen EVP, Finance & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
19,000
+17.81%
|
$741,000
$39.87 P/Share
|
|
Nov 23
2020
|
Stanley T Crooke Exec Chairman of the Board |
SELL
Open market or private sale
|
Direct |
11,600
-85.16%
|
$580,000
$50.11 P/Share
|
|
Nov 23
2020
|
Stanley T Crooke Exec Chairman of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
11,600
+45.99%
|
$452,400
$39.87 P/Share
|
|
Nov 23
2020
|
Stanley T Crooke Exec Chairman of the Board |
SELL
Open market or private sale
|
Indirect |
500
-24.03%
|
$25,000
$50.0 P/Share
|
|
Nov 23
2020
|
Stanley T Crooke Exec Chairman of the Board |
BUY
Exercise of conversion of derivative security
|
Indirect |
500
+19.37%
|
$19,500
$39.87 P/Share
|
|
Nov 03
2020
|
C Frank Bennett EVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
15,000
-31.59%
|
$690,000
$46.77 P/Share
|
|
Nov 03
2020
|
C Frank Bennett EVP, Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+24.01%
|
$585,000
$39.87 P/Share
|
|
Oct 20
2020
|
Joseph Klein Iii Director |
SELL
Open market or private sale
|
Direct |
2,889
-17.32%
|
$132,894
$46.86 P/Share
|
|
Oct 15
2020
|
Peter N Reikes Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,778
+25.0%
|
-
|
|
Oct 15
2020
|
Michael R Hayden Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,778
+25.0%
|
-
|